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Abstract
Background and Purpose: Laparoscopic retroperitoneal lymph node dissection (L-RPLND) is emerging as a
viable alternative to traditional open retroperitoneal lymph node dissection (O-RPLND). Despite numerous
reports confirming clinical oncologic equivalency between the two approaches, however, concerns still remain
over the adequacy of laparoscopic dissection. We therefore sought to compare the completeness of dissection
between O-RPLND and L-RPLND in a porcine model.
Materials and Methods: Fourteen domestic swine were divided into two equivalent groups. Both groups un-
derwent bilateral retroperitoneal lymph node dissection, approximating templates used in human dissection. In
one group, the procedure was performed through an open midline incision, while the other group underwent
completely laparoscopic dissection. Tissue was independently analyzed by a pathologist, who recorded lymph
node yield based on microscopic evaluation.
Results: All animals in the L-RPLND group underwent successful procedures, without the need for conversion.
Two open procedures were aborted because of hemorrhage. Mean lymph node yield from O-RPLND was 32,
while the mean yield for L-RPLND was 29. This difference was not statistically significant (P¼ 0.65).
Conclusions: In the porcine model, L-RPLND is capable of providing a quality of dissection equivalent to that of
O-RPLND, in terms of absolute lymph node yield on microscopic examination. The applicability of this data to
human patients, however, may be limited by significant anatomic differences between the human and the pig.
Further prospective comparison in human patients is critically needed.
Introduction
Despite numerous advances in minimally invasiveurologic oncology, open retroperitoneal lymph node
dissection (O-RPLND) remains the gold standard for the sur-
gical management of low-stage nonseminomatous germ-cell
tumors.1 Recent reports, however, indicate that laparoscopic
retroperitoneal lymph node dissection (L-RPLND) may be a
viable alternative to the open approach.2–10
One of the major concerns surrounding L-RPLND has been
its adequacy as a stand-alone procedure that does not require
the use of adjuvant chemotherapy in the instance of incom-
plete dissection.11,12 Indeed, while initial long-term studies
have demonstrated oncologic outcomes equivalent to an open
approach,2,3,5,8,10 there is a paucity of literature directly
comparing the lymph node yield between L-RPLND and
O-RPLND, with one recent direct comparison suggesting that
node counts are significantly less with the laparoscopic ap-
proach,9 while another meta-analysis suggests that node
counts may be the same between the two approaches at high-
volume centers.8
To further explore this critical and controversial aspect of
the advanced surgicalmanagement of testis cancer, we sought
to explore the adequacy and completeness of dissection of
L-RPLND, compared to O-RPLND, using an animal model.
Materials and Methods
After approval from our institutional animal care and use
committee, 14 domestic swine were divided into two equiv-
alent groups consisting of seven animals each.GroupAunder-
went O-RPLND, while group B underwent transperitoneal
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L-RPLND. Both underwent bilateral lymph node dissection,
approximating modified template dissections previously
described by Donohue and associates.13,14 Briefly, the bound-
aries of dissection were defined by the renal vessels superi-
orly, the ureters laterally, and the common iliac arteries
inferiorly. Nerve-sparing procedures were not attempted in
this animal model.
For the open approach, the pigs were placed in a supine
position, and a midline laparotomy incision was made. The
peritoneum was incised along the white line of Toldt, and
the bowel was reflected cephalad to expose the retroperito-
neum. Full dissection was performed, using a ‘‘split-and-roll’’
technique to obtain lymph node tissue circumferentially.
For the laparoscopic approach, a transperitoneal technique
similar to that described by Janetschek and colleagues15 was
used. The pig was placed initially in a right lateral decubitus
position for left-sided dissection. Three ports were arranged
in a triangular configuration, with additional ports placed as
necessary for bowel retraction. After completion of the left
side, the animal was repositioned in the left lateral decubitus
position for right-sided dissection. Again, a split-and-roll
technique was used to ensure a complete dissection.
A combination of sharp and blunt dissection as well as
Bovie electrocautery was used in all open cases, while energy
was delivered with a LigaSure device (ValleyLab, Boulder,
CO) during the laparoscopic procedures. At the conclusion of
each procedure, the animals were humanely sacrificed ac-
cording to institutional protocol.
Lymph node packets were then analyzed by a single pa-
thologist (PAH), who recorded the overall size of each lymph
node packet, as well as the total gross number of nodes col-
lected from each dissection. In addition, microscopic exami-
nation and confirmation of node count was performed after
paraffin embedding and sectioning, along with hematoxylin
and eosin staining. Statistical comparison of lymph node
counts between O-RPLND and L-RPLND was then per-
formed using a two-tailed Student’s t-test, after normality of
distribution and equal variance of our samples was confirmed
with a Shapiro-Wilk test, and an F test, respectively.
Results
Histologic data are summarized in Table 1.Mean size of the
animals was 41 kg and was equivalent between the two
groups. O-RPLND was completed in five animals; two of the
animals in the O-RPLND group experienced major operative
misadventures resulting in exsanguination before lymph
node dissection could be completed. This occurred early in
the laboratory experience. In the L-RPLND group, the pro-
cedure was completed in all seven animals without intra-
operative complications or the need for open conversion.
Pathologic evaluation revealed a mean aggregate packet
size of 4.34.1 cm for O-RPLND, and 4.74.8 cm for
L-RPLND. Mean aggregate lymph node yield for O-RPLND
was 32 lymph nodes (range 16–49), and 29 lymph nodes for
L-RPLND (range 18–40). The aggregate lymph node yieldwas
equivalent between the two approaches (P¼ 0.65).
Subset analysis evaluating the adequacy of dissection for
both left- and right-sided dissections, based on the boundaries
of modified unilateral templates, revealed no difference in
mean lymph node yield for left- and right-sided dissec-
tions for O-RPLND (16.8 v 15.0, respectively, P¼ 0.7). For
L-RPLND, however, significantly more nodes were obtained
during left-sided dissection, compared with the right-sided
dissection (19.4 v 9.6, respectively, P¼ 0.005). When compar-
ing the left- and right-sided yield between both open and
laparoscopic approaches, the difference in unilateral lymph
node yield for both sides was not statistically different
between the two modalities.
Discussion
Testis cancer is currently the most common genitourinary
malignancy affecting young postpubertal males. Fortunately,
advances in the understanding of the natural history of the
disease, along with refinements in surgical and medical
therapy, have resulted in a drastic decrease in cancer-related
deaths over the past 40 years.11,16–18
For patients with low-stage nonseminomatous testis tu-
mors, retroperitoneal lymph node dissection remains one vi-
able option for secondary management after orchiectomy,
along with chemotherapy or active surveillance. RPLND is
perhaps unique among the three strategies in that it is able
to provide accurate pathologic staging of the disease in ad-
dition to the potential for eradication of metastatic disease
to the retroperitoneum,1–3,5,7,11 which is found in approxi-
mately 30% of patients with low-stage nonseminomatous
disease.1,19
Table 1. Comparison of Microscopic Lymph Node Count for Open and Laparoscopic Retroperitoneal
Lymph Node Dissection
O-RPLND L-RPLND
Subject Left Right Total Left Right Total
1 13 15 28 14 4 18
2 12 14 26 25 15 40
3 8 8 16 24 0 24
4 26 23 49 15 12 27
5 25 15 40 15 13 28
6 N=A N=A N=A 19 8 27
7 N=A N=A N=A 24 15 39
Mean count 16.8 15.0 31.8 19.4 9.6 29.0
O-RPLND¼open retroperitoneal lymph node dissection; L-RPLND¼ laparoscopic retroperitoneal lymph node dissection.
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L-RPLNDwas first described by Rukstalis and Chodak20 in
1992, for a 19-year-oldmanwith low-stage nonseminomatous
disease. While their report demonstrated the feasibility of a
laparoscopic approach, the authors were unable to perform a
complete dissection that included tissue posterior to the great
vessels, thus raising concerns over the adequacy of dissection
via a laparoscopic approach.
In the ensuing years, advancements in technique and
minimally invasive technology have allowed surgeons to
more adequately replicate the open technique.4,21,22 Indeed,
recent reports of long-term outcomes of L-RPLND indicate
that oncologic efficacy in terms of disease-free and disease-
specific survival is equivalent to that of O-RPLND.2,3,5–8,10,23
In addition, high-volume centers report that, in experi-
enced hands, L-RPLND is associated with less morbidity,
shorter hospital stays, and fewer overall complications com-
pared with O-RPLND, while demonstrating inferiority only
in terms of increased operative time and slightly increased
overall costs.3,5,8–10,21,24–26 Furthermore, L-RPLND has been
demonstrated to be associated with less bother from postop-
erative pain comparedwith O-RPLND, aswell as faster return
to normal daily activities and improved quality of life scores
on validated questionnaires.24
Despite the numerous potential advantages of L-RPLND,
the technique has struggled to make inroads as the preferred
modality for intervention at many high-volume centers,22
based primarily on the concern that L-RPLND is incapable of
providing an equivalent dissection to O-RPLND.11,12 Indeed,
while clinical oncologic outcomes may be similar, few stud-
ies have directly compared institutional experiences with
L-RPLND and O-RPLND, with emphasis on objective meas-
urement of the technical adequacy of dissection. While a
meta-analysis of results from high-volume centers did note
equivalency between the open and laparoscopic approaches
in terms of lymph node yield,8 one retrospective single-
institution series demonstrated nearly double the lymph node
count for O-RPLND, compared with L-RPLND (33 v 17, res-
pectively, P¼ 0.005).9
To our knowledge, however, no prospective comparison
of the adequacy of dissection offered by O-RPLND and
L-RPLND has been described in the literature. We therefore
sought to evaluate lymph node yield with both open and
laparoscopic RPLND using an animal model.
Our results demonstrate that, for bilateral retroperitoneal
lymphadenectomy, L-RPLND is capable of providing lymph
node yields equivalent to the open approach in a porcine
model. In fact, while there was no significant difference
between the two approaches in terms of overall tissue mass
excised, there was a trend toward larger specimens in the
L-RPLND group, indicating little difficultly in extracting
whole, intact tissue packets via aminimally invasive approach.
There are potential limitations to our present study, some of
which may limit the applicability of our results to the treat-
ment of human patients with low-stage nonseminomatous
disease. Sample sizes in our experimental investigation were
admittedly small. Furthermore, in the open group, two pro-
cedures had to be aborted because of exsanguination, which
further limited the size of the open cohort. While statistical
analysis was able to be successfully performed, it is never-
theless possible that our study was underpowered.
Furthermore, we are unable to clearly identify the factors
that contributed to the noted discrepancy between lymph
node yield for left- and right-sided dissections in our
L-RPLND experience, a difference that was not noted in the
O-RPLND cohort. Potential explanations include the possi-
bility of increased technical challenge for right-sided dissec-
tions via a laparoscopic approach, or erroneous inclusion of
right-sided lymph node tissue in the packets obtained from
the left-sided dissections. That said, when comparing the
adequacy of unilateral dissection, no statistical difference
could be identified between the open and laparoscopic ap-
proaches for either side, and thus the practical implications of
this discrepancy remain unclear.
In addition, the RPLND procedures performed in this ex-
perimental model were on animals with no pathologic diag-
nosis, and presumably normal lymph node tissue. Our
dissections were carried out with the intent of providing as
complete a dissection as technically possible in both arms of
the study. Nevertheless, our experimental model may inade-
quately replicate dissections that are performed on patholog-
ically abnormal nodal tissue, or in postchemotherapy patients.
Finally, we must acknowledge that there are significant
anatomic differences between humans and pigs in terms of
retroperitoneal lymph node distribution, and that these dif-
ferences may limit the applicability of our results to a human
model. In the pig, we noted that the bulk of the lymphatic
tissue was found in the region of the renal pedicle, and along
the iliac vessels, while the interaortocaval region—a territory
rich with tissue in the human—was relatively devoid of
lymphatic tissue in the pig. That said, our study was intended
simply as a preliminary experimental investigation before
undertaking direct prospective comparison of techniques in
human patients. In this regard, our reported experimental
model is similar to other published investigational studies,
which have also used a porcine model,15,27–29 often with
successful transition thereafter to human studies.27,29 Indeed,
investigation of the efficacy and long-term outcomes of
L-RPLND in humans at our institution is currently under-
way,6 although reports of long-term prospective comparison
of lymph node yields between the open and laparoscopic
approaches in humans is currently lacking.
Conclusions
Despite early concerns over its efficacy as a curative pro-
cedure, L-RPLND continues to establish itself as a viable al-
ternative to O-RPLND, offering less morbidity and increased
patient satisfaction, while providing equivalent oncologic
outcomes in the hands of experienced surgeons. In the porcine
model, L-RPLND is capable of providing lymph node yields
equivalent to O-RPLND, further supporting the potential for
oncologic equivalency via a minimally invasive approach.
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Abbreviations Used
L-RPLND¼ laparoscopic retroperitoneal lymph node
dissection
O-RPLND¼ open retroperitoneal lymph node dissection
RPLND¼ retroperitoneal lymph node dissection
488 BENWAY ET AL.
